Telix Pharmaceuticals Launches $50M Underwritten Initial Public Offering

MELBOURNE (Australia) – 23 October 2017. Telix Pharmaceuticals Limited today announces the opening of its Initial Public Offering to raise A$50 million.

Telix Pharmaceuticals Limited is pleased to announce the opening of its Initial Public Offering to raise A$50 million.

Click here to view the full release.